Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
metabolic syndrome 2 endocrinologydiseases
obesity 1 endocrinologydiseases
type 2 diabetes mellitus 1 endocrinologydiseases
diabetes mellitus 3 endocrinologydiseases
hyperglycemia 3 endocrinologydiseases
hyperuricemia 1 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
diabetes mellitus 482 determinant of the severity of myocardial damage and mortality after coronary artery occlusion. Type 2 diabetes mellitus (T2DM) represents an important risk factor for impaired collateral vessel growth. However, the mechanism
diabetes mellitus 3611 grade 3) supplied by the right coronary arteryEpidemiological data frequently demonstrate that type 2 diabetes mellitus (T2DM) is increasingly prevalent and represents an important risk factor for cardiovascular disease
diabetes mellitus 14732 ligand and decreased concentrations of angiostatic ligands, and interferon-c [[53]]. It is known that diabetes mellitus aggressively induces atherosclerosis and may be more susceptible to myocardial infarction. Furthermore,
hyperglycemia 8524 pericyte loss compared to nondiabetic explants. Moreover, they found that in a diabetic pig model, hyperglycemia induced microvascular rarefaction in the myocardium even without ischemia, and capillary density further
hyperglycemia 9189 All these changes jointly lead to reduced arteriogenic property in type 2 diabetic patients.Chronic hyperglycemia and altered redox state in diabetes increase the formation and accumulation of advanced glycation endproducts
hyperglycemia 12842 syndrome characterized by a cluster of risk components including abdominal obesity, insulin resistance, hyperglycemia , dyslipidemia and hypertension has been considered as one of the significant factors affecting adversely
hyperuricemia 14099 [[39]], traditional risk factors for coronary artery disease [[40]–[44]], hyperlipoprotein (a) [[45]], hyperuricemia [[46]] and elevated serum levels of CRP [[47]], TNF-a [[48]], N-terminal pro-brain natriuretic peptide
metabolic syndrome 11274 anti-lymphangiogenic property and its serum levels are related to insulin resistance in patients with metabolic syndrome , whereas the biological effect of soluble VEGFR-3 remains unclear [[28]]. These results suggest that
metabolic syndrome 13318 growth [[36]]. Previous studies indicated that an increasing number of component pathologies of the metabolic syndrome correlated with increasingly poorer coronary collateral development by angiographic grading systems
obesity 12813 collateral growth.Metabolic syndrome characterized by a cluster of risk components including abdominal obesity , insulin resistance, hyperglycemia, dyslipidemia and hypertension has been considered as one of the
type 2 diabetes mellitus 3604 (Rentrop grade 3) supplied by the right coronary arteryEpidemiological data frequently demonstrate that type 2 diabetes mellitus (T2DM) is increasingly prevalent and represents an important risk factor for cardiovascular disease

You must be authorized to submit a review.